1,2-dipalmitoylphosphatidylcholine has been researched along with Hyperventilation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bates, SR; Dodia, C; Fisher, AB; Hawgood, S; Jain, D; Poulain, FR | 1 |
Inchley, K; Lewis, JF; Maitra, G; Novick, RJ; Possmayer, F; Veldhuizen, RA | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Hyperventilation
Article | Year |
---|---|
SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Disease Models, Animal; Endocytosis; Hyperventilation; Lysosomes; Mice; Mice, Knockout; Phospholipases A; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein A; Stem Cells; Tritium | 2003 |
Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Disease; Animals; Dogs; Enzyme Inhibitors; Hyperventilation; Ischemia; Lipids; Lung Diseases; Lung Transplantation; Phenylmethylsulfonyl Fluoride; Protein Isoforms; Pulmonary Circulation; Pulmonary Surfactants; Reference Values | 2002 |